CannaPharmaRX, Inc. – OTC:CPMD

CannaPharmaRX stock price today

$0.003
-0.00
-57.33%
Financial Health
0
1
2
3
4
5
6
7
8
9

CannaPharmaRX stock price monthly change

-20.00%
month

CannaPharmaRX stock price quarterly change

-20.00%
quarter

CannaPharmaRX stock price yearly change

+344.44%
year

CannaPharmaRX key metrics

Market Cap
3.34M
Enterprise value
16.30M
P/E
-0.07
EV/Sales
N/A
EV/EBITDA
-1.69
Price/Sales
N/A
Price/Book
-0.13
PEG ratio
N/A
EPS
-0.02
Revenue
N/A
EBITDA
-2.26M
Income
-6.61M
Revenue Q/Q
N/A
Revenue Y/Y
3.67%
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

CannaPharmaRX stock price history

CannaPharmaRX stock forecast

CannaPharmaRX financial statements

CannaPharmaRX, Inc. (OTC:CPMD): Profit margin
Jun 2023 0 -1.87M
Sep 2023 0 -564.36K
Dec 2023 32 7.54M 23578065.63%
Mar 2024 25.83K -11.71M -45340.89%
CannaPharmaRX, Inc. (OTC:CPMD): Debt to assets
Jun 2023 5322938 25.46M 478.44%
Sep 2023 5155989 25.78M 500.12%
Dec 2023 11745650 23.89M 203.47%
Mar 2024 11366015 34.89M 307.02%
CannaPharmaRX, Inc. (OTC:CPMD): Cash Flow
Jun 2023 -482.16K -73.80K 460.59K
Sep 2023 123.87K -4.18K 92.68K
Dec 2023 -1.30M -1.75K 1.30M
Mar 2024 -548.82K 0 560.27K

CannaPharmaRX alternative data

CannaPharmaRX, Inc. (OTC:CPMD): Employee count
Aug 2023 4
Sep 2023 4
Oct 2023 6
Nov 2023 6
Dec 2023 6
Jan 2024 6
Feb 2024 6
Mar 2024 6
Apr 2024 6
May 2024 6
Jun 2024 6
Jul 2024 21

CannaPharmaRX other data

CannaPharmaRX, Inc. (OTC:CPMD): Insider trades (number of shares)
Period Buy Sel
Jan 2019 600000 0
Apr 2019 0 5200
Jun 2019 0 4000
Oct 2019 0 1000000
Transaction Date Insider Security Shares Price per share Total value Source
Sale
COLVIN DOMINIC director, officer: Chief Execut..
Common Stock 1,000,000 $0.25 $250,000
Sale
NICOSIA MATTHEW director, 10 percent owner:
Series A Preferred 4,000 N/A N/A
Sale
SAMUELSON JAMES F director, 10 percent owner:
Series A Convertible Preferred Stock 4,000 N/A N/A
Sale
SAMUELSON JAMES F director, 10 percent owner:
Series A Convertible Preferred Stock 1,200 N/A N/A
Purchase
HERICK GARY J director, officer: Chief Financ..
Common Stock 100,000 $2 $200,000
Purchase
HERICK GARY J director, officer: Chief Financ..
Common Stock 100,000 $2 $200,000
Purchase
HERICK GARY J director, officer: Chief Financ..
Common Stock 400,000 $2 $800,000
Sale
HERICK GARY J director, officer: Chief Financ..
Common Stock 2,500 $0.5 $1,250
Sale
HERICK GARY J director, officer: Chief Financ..
Common Stock 3,000 $0.5 $1,500
Sale
HERICK GARY J director, officer: Chief Financ..
Common Stock 3,000 $0.5 $1,500
Insider Compensation
Mr. Andrew Clifford Steedman (1961) Chief Operations Officer
$94,250
Mr. John Hamilton Cassels CPA, C.A. (1948) Chief Financial Officer & Sec.
$94,250
Mr. Dominick Colvin (1968) Chief Executive Officer, Pres & Director
$94,250
Tuesday, 5 November 2024
accesswire.com
Thursday, 15 August 2024
accesswire.com
Friday, 28 June 2024
accesswire.com
  • What's the price of CannaPharmaRX stock today?

    One share of CannaPharmaRX stock can currently be purchased for approximately $0.

  • When is CannaPharmaRX's next earnings date?

    Unfortunately, CannaPharmaRX's (CPMD) next earnings date is currently unknown.

  • Does CannaPharmaRX pay dividends?

    No, CannaPharmaRX does not pay dividends.

  • How much money does CannaPharmaRX make?

    CannaPharmaRX has a market capitalization of 3.34M.

  • What is CannaPharmaRX's stock symbol?

    CannaPharmaRX, Inc. is traded on the OTC under the ticker symbol "CPMD".

  • What is CannaPharmaRX's primary industry?

    Company operates in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry.

  • How do i buy shares of CannaPharmaRX?

    Shares of CannaPharmaRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are CannaPharmaRX's key executives?

    CannaPharmaRX's management team includes the following people:

    • Mr. Andrew Clifford Steedman Chief Operations Officer(age: 64, pay: $94,250)
    • Mr. John Hamilton Cassels CPA, C.A. Chief Financial Officer & Sec.(age: 77, pay: $94,250)
    • Mr. Dominick Colvin Chief Executive Officer, Pres & Director(age: 57, pay: $94,250)
  • How many employees does CannaPharmaRX have?

    As Jul 2024, CannaPharmaRX employs 21 workers, which is 250% more then previous month and 250% more then previous quarter.

  • When CannaPharmaRX went public?

    CannaPharmaRX, Inc. is publicly traded company for more then 10 years since IPO on 16 Apr 2015.

  • What is CannaPharmaRX's official website?

    The official website for CannaPharmaRX is cannapharmarx.com.

  • Where are CannaPharmaRX's headquarters?

    CannaPharmaRX is headquartered at 888-3rd Street SW, Calgary, AB.

  • How can i contact CannaPharmaRX?

    CannaPharmaRX's mailing address is 888-3rd Street SW, Calgary, AB and company can be reached via phone at +94 96526838.

CannaPharmaRX company profile:

CannaPharmaRX, Inc.

cannapharmarx.com
Exchange:

OTC

Full time employees:

4

Industry:

Drug Manufacturers—Specialty & Generic

Sector:

Healthcare

CannaPharmaRX, Inc. operates in the cannabis industry in Canada. It negotiates, acquires, and develops various cannabis cultivation projects. The company was incorporated in 1998 and is based in Calgary, Canada.

888-3rd Street SW
Calgary, AB T2P 5C5

CIK: 0001081938
ISIN: US13765D1090
CUSIP: 13765D109